Observational Study on Patients With Hepatobiliary Tumors

This is an ongoing, longitudinal, single centre, observational clinical cohort study of patients with hepatobiliary tumors. All the patients are diagnosed, treated and followed up by The First Affiliate hospital of Wenzhou medical university.

Hepatobiliary tumors have a poor prognosis and high individual heterogeneity, the patient with hepatobiliary tumors even accepted radical surgery, the postoperative recurrence rate is still high. Therefore, it is of great significance to find important prognostic markers to improve patient prognosis and formulate new treatment plans after surgery. In recent years, targeted therapy and immunotherapy make cancer treatment enter a new field, However, tumor heterogeneity is the greatest challenge in cancer therapeutics and biomarkers discovery. In this study, we obtained blood and pathological tissue specimens from tumor patients, then Multi-omics testing were applied to Looking for novel therapeutic targets and prognostic markers to predict patient response to treatment. Clinicians choose the best treatment plan for the patient based on the test results to improve the patient's survival time and quality of life.

Observational Study on Patients With Hepatobiliary Tumors

Recruitment

Summary

Participation Requirements

Description

Tracking Information